Eton Pharmaceuticals Inc
NASDAQ:ETON
Eton Pharmaceuticals Inc
NASDAQ:ETON
Price:
3.75 USD
1.9%
Market Closed
Updated:
May 3, 2024
Eton Pharmaceuticals Inc
Cash from Financing Activities
|
Eton Pharmaceuticals Inc
Cash from Financing Activities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Eton Pharmaceuticals Inc
NASDAQ:ETON
|
Cash from Financing Activities
-$957k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$15.8B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
$8.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$4.8B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-5%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Eton Pharmaceuticals Inc's Cash from Financing Activities?
Cash from Financing Activities
-957k
USD
-957k
USD
Based on the financial report for Dec 31, 2023, Eton Pharmaceuticals Inc's Cash from Financing Activities amounts to -957k USD.
What is Eton Pharmaceuticals Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-636%
-636%
Over the last year, the Cash from Financing Activities growth was -636%.
You don't have any saved screeners yet
